{
    "patient": {
        "Name": "Zoe Johnson",
        "DateOfBirth": "1971-06-01",
        "Sex": "Male",
        "Diagnosis": "Neuroendocrine tumors",
        "BodyPart": "Colorectal",
        "Physician": "Dr. Andrew Lang",
        "TreatingInstitution": "Willis-Ramos"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Colorectal",
            "CollectedDate": "2024-03-30",
            "ReceivedDate": "2024-04-02",
            "TumorPercentage": "25%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2024-04-04",
            "ReceivedDate": "2024-04-04"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "DPYD",
                "DNA Alteration": "c.557A>G",
                "GeneMutation": "p.I543V Frameshift-GOF",
                "VariantAlleleFraction": "34.26%"
            },
            {
                "Gene": "H3.3",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.G35R Stopgain-LOF",
                "VariantAlleleFraction": "6.13%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "PTCH1",
                "DNA Alteration": "c.3583A>T",
                "GeneMutation": "p.T1195S Nonsense-LOF",
                "VariantAlleleFraction": "12.78%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "TOP2A",
            "KRAS",
            "BLM",
            "FBXW7",
            "PHF6"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "19 m/Mb",
            "Tmbpercentile": "74%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Equivocal"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}